Smith & Nephew plc (LON:SN)
London · Delayed Price · Currency is GBP · Price in GBX 1,274.00
+24.00 (1.92%)
Feb 4, 2026, 1:24 PM GMT
Smith & Nephew Market Cap
Smith & Nephew has a market cap or net worth of 10.62 billion as of February 4, 2026. Its market cap has increased by 17.52% in one year.
Market Cap
10.62B
Enterprise Value
12.65B
Revenue
4.33B
Ranking
n/a
PE Ratio
30.71
Stock Price
1,274.00
Market Cap Chart
Since December 31, 1985, Smith & Nephew's market cap has increased from 819.93M to 10.62B, an increase of 1,195.48%. That is a compound annual growth rate of 6.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 2, 2026 | 10.63B | 0.97% |
| Dec 31, 2025 | 10.52B | 21.72% |
| Dec 31, 2024 | 8.65B | -7.88% |
| Dec 29, 2023 | 9.39B | -2.72% |
| Dec 30, 2022 | 9.65B | -15.11% |
| Dec 31, 2021 | 11.36B | -14.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 210.92B |
| GSK plc | 75.29B |
| Haleon | 33.75B |
| Convatec Group | 4.48B |
| Hikma Pharmaceuticals | 3.39B |
| Genus | 2.11B |
| HUTCHMED (China) | 1.89B |
| Oxford Nanopore Technologies | 1.50B |